Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
#
|
Topic
|
Subspecialty
|
Importance
|
Questions
|
---|---|---|---|---|
151 | COVID-19/SARSCOV2 | Respiratory | 0 | |
152 | Principles of Neoplasia | Oncology | 4 | |
153 | Tumor Nomenclature | Oncology | 2 | |
154 | Oncogenes | Oncology | 2 | |
155 | Tumor Suppressor Genes | Oncology | 5 | |
156 | Tumor Markers | Oncology | 3 | |
157 | Oncogenic Viruses | Oncology | 2 | |
158 | Chemical Carcinogens | Oncology | 1 | |
159 | Paraneoplastic Effects of Tumors | Oncology | 0 | |
160 | Metastasis | Oncology | 3 | |
161 | Cancer Epidemiology | Oncology | 0 | |
162 | Vitiligo | Dermatology | 3 | |
163 | Hepatic Adenoma | Oncology | 1 | |
164 | Hepatocellular Carcinoma (HCC) | Oncology | 4 | |
165 | Angiosarcoma | Oncology | 2 | |
166 | Gallbladder Adenocarcinoma | Oncology | 1 | |
167 | Cholangiocarcinoma | Oncology | 2 | |
168 | Salivary Gland Tumors | Oncology | 1 | |
169 | Esophageal Cancer | Oncology | 3 | |
170 | Gastric Cancer | Oncology | 4 | |
171 | Colorectal Cancer (CRC) | Oncology | 5 | |
172 | Anal Cancer | Oncology | 1 | |
173 | Chronic Myeloid Leukemia (CML) | Oncology | 2 | |
174 | Pancreatic Cancer | Oncology | 2 | |
175 | Hodgkin vs. Non-Hodgkin Lymphoma | Oncology | 0 | |
176 | Hodgkin Lymphoma | Oncology | 2 | |
177 | Non-Hodgkin Lymphoma | Oncology | 3 | |
178 | Multiple Myeloma | Oncology | 7 | |
179 | Mycosis Fungoides / Sezary Syndrome | Oncology | 1 | |
180 | Langerhans Cell Histiocytoses | Oncology | 2 | |
181 | Waldenstrom Macroglobulinemia | Oncology | 1 | |
182 | Cancer Drugs Overview | Oncology | 1 | |
183 | Targeted Therapy | Oncology | 4 | |
184 | Antimetabolites | Oncology | 6 | |
185 | Antitumor Antibiotics | Oncology | 2 | |
186 | Alkylating Agents | Oncology | 2 | |
187 | Microtubule Inhibitors | Oncology | 4 | |
188 | Platinum Analogs | Oncology | 2 | |
189 | Acute Lymphoblastic Leukemia (ALL) | Oncology | 6 | |
190 | Parathyroid Adenoma | Oncology | 2 | |
191 | Thyroid Cancer | Oncology | 5 | |
192 | Adult T-Cell Leukemia / Lymphoma (ATLL) | Oncology | 0 | |
193 | Vulvar Cancer | Oncology | 0 | |
194 | Adenomyosis | Reproductive | 3 | |
195 | Abruptio Placentae | Reproductive | 1 | |
196 | Amenorrhea / Anovulation | Reproductive | 2 | |
197 | Seborrheic Keratosis | Dermatology | 3 | |
198 | Urticaria | Dermatology | 3 | |
199 | Endometrial Carcinoma | Oncology | 2 | |
200 | Skin Anatomy and Wound Healing | Dermatology | 1 | |
201 | Benign Bone Tumors | Oncology | 4 | |
202 | Malignant Bone Tumors | Oncology | 7 | |
203 | Soft Tissue Tumors | Oncology | 2 | |
204 | Terminology of Skin Lesions | Dermatology | 1 | |
205 | Staphylococcal Scalded Skin Syndrome (SSSS) | Dermatology | 3 | |
206 | Stevens-Johnson Syndrome | Dermatology | 2 | |
207 | Tinea Versicolor | Dermatology | 0 | |
208 | Tinea Corporis | Dermatology | 0 | |
209 | Tinea Capitis | Dermatology | 0 | |
210 | Tinea Pedis / Manuum | Dermatology | 0 | |
211 | Tinea Cruris | Dermatology | 0 | |
212 | Primary Brain Tumors | Oncology | 11 | |
213 | Melanoma | Oncology | 6 | |
214 | Renal Cell Carcinoma | Oncology | 5 | |
215 | Wilms Tumor | Oncology | 1 | |
216 | Bladder Cancer | Oncology | 3 | |
217 | Androgens | Reproductive | 1 | |
218 | Androgen Insensitivity Syndrome / Testicular Feminization | Reproductive | 4 | |
219 | 5-Alpha Reductase Deficiency | Reproductive | 3 | |
220 | Cervical Cancer | Oncology | 2 | |
221 | Ovarian Tumors | Oncology | 5 | |
222 | Choriocarcinoma | Oncology | 2 | |
223 | Vaginal Carcinoma | Oncology | 2 | |
224 | Benign Breast Tumors | Reproductive | 2 | |
225 | Malignant Breast Tumors | Oncology | 5 | |
226 | Benign Prostatic Hyperplasia (BPH) | Reproductive | 6 | |
227 | Prostate Cancer | Oncology | 3 | |
228 | Testicular Tumors | Oncology | 3 | |
229 | Penis Cancer | Oncology | 1 | |
230 | Antiandrogens | Reproductive | 4 | |
231 | Clomiphene | Reproductive | 1 | |
232 | Combined Oral Contraceptive Pill (COCP) | Reproductive | 0 | |
233 | Airways | Respiratory | 4 | |
234 | Microanatomy of the Lung | Respiratory | 7 | |
235 | Pressure-Volume Curve | Respiratory | 3 | |
236 | Bronchopulmonary Segments | Respiratory | 0 | |
237 | Lung Relationships | Respiratory | 1 | |
238 | Diaphragm | Respiratory | 0 | |
239 | Muscles of Respiration | Respiratory | 0 | |
240 | Important Lung Products | Respiratory | 1 | |
241 | Lung Volumes and Capacities | Respiratory | 2 | |
242 | Dead Spaces and Ventilation Rates | Respiratory | 2 | |
243 | Diffusion-Limited and Perfusion-Limited Oxygen Transport | Respiratory | 1 | |
244 | Oxygen Transport and Hemoglobin | Respiratory | 1 | |
245 | Essential Thrombocytosis | Oncology | 1 | |
246 | Oxygen-Hemoglobin Dissociation Curve | Respiratory | 1 | |
247 | Diffusion-Limited and Perfusion-Limited Gas Exchange | Respiratory | 0 | |
248 | Pulmonary Hypertension | Respiratory | 8 | |
249 | Oxygen Content of Blood | Respiratory | 1 | |
250 | Polycythemia Vera | Oncology | 4 | |
251 | Oxygen Deprivation | Respiratory | 5 | |
252 | V/Q Mismatch | Respiratory | 4 | |
253 | Carbon Dioxide Transport | Respiratory | 2 | |
254 | Response to High Altitude | Respiratory | 3 | |
255 | Response to Exercise | Respiratory | 3 | |
256 | Pulmonary Thromboembolism | Respiratory | 6 | |
257 | Bronchiectasis | Respiratory | 2 | |
258 | Restrictive Lung Disease Overview | Respiratory | 1 | |
259 | Pneumoconioses | Respiratory | 8 | |
260 | Neonatal Respiratory Distress Syndrome | Respiratory | 10 | |
261 | Acute Respiratory Distress Syndrome (ARDS) | Respiratory | 6 | |
262 | Obstructive Lung Disease Overview | Respiratory | 0 | |
263 | Sleep Apnea | Respiratory | 5 | |
264 | Pulmonary Physical Findings | Respiratory | 0 | |
265 | Lung Cancer | Oncology | 13 | |
266 | Pancoast Tumor | Oncology | 4 | |
267 | Pneumonia | Respiratory | 4 | |
268 | Pleural Effusion | Respiratory | 4 | |
269 | H1 Blockers | Respiratory | 4 | |
270 | Asthma Drugs | Respiratory | 12 | |
271 | Expectorants | Respiratory | 4 | |
272 | Pulmonary Hypertension Drugs | Respiratory | 4 | |
273 | Chronic Bronchitis | Respiratory | 8 | |
274 | Emphysema | Respiratory | 10 | |
275 | Shunts | Respiratory | 1 | |
276 | Sarcoidosis | Respiratory | 11 | |
277 | Other Restrictive Etiologies | Respiratory | 8 | |
278 | Fat Embolus Syndrome | Respiratory | 2 | |
279 | Asthma | Respiratory | 14 | |
280 | Pneumothorax | Respiratory | 4 | |
281 | Pulmonary Edema | Respiratory | 2 | |
282 | Sinusitis | Respiratory | 1 | |
283 | Nasal Polyps | Respiratory | 1 | |
284 | Airflow, Pressure, and Resistance | Respiratory | 2 | |
285 | Cryptogenic Organizing Pneumonia | Respiratory | 2 | |
286 | Supplemental Oxygen-Induced Hypercapnia | Respiratory | 0 | |
287 | Croup | Respiratory | 2 | |
288 | Myelofibrosis | Oncology | 3 | |
289 | Hairy Cell Leukemia (HCL) | Oncology | 2 | |
290 | Chronic Lymphocytic Leukemia (CLL) | Oncology | 1 | |
291 | Acute Myelogenous Leukemia (AML) | Oncology | 6 | |
292 | Squamous Cell Carcinoma (SCC) of the Skin | Oncology | 7 | |
293 | Basal Cell Carcinoma of the Skin | Oncology | 2 | |
294 | Cystic Fibrosis | Respiratory | 12 | |
295 | Cyanide Poisoning | Respiratory | 0 | |
296 | Carbon Monoxide Poisoning | Respiratory | 1 | |
297 | Mesothelioma | Oncology | 0 | |
298 | Desmoid Tumors | Oncology | 0 | |
299 | Bacterial Tracheitis | Respiratory | 0 | |
300 | Aromatase Deficiency | Reproductive | 0 |